Nissha Co.ltd. · TSE:7915
Nissha Co.ltd — FY2025 Q1 Earnings Presentation
12 slides from Nissha Co.ltd's earnings presentation, May 9, 2025
Slide 1: Financial Results for FY2025 Q1
Financial Results for FY2025 Q1 Ended March 31, 2025 May 9, 2025 Junya Suzuki Chairman of the Board and Group CEO Nissha Co., Ltd.
Slide 2: Highlights
Highlights FY2025 Q1 Results Tailwinds Increased both YoY and QoQ in net sales and operating profit Industrial Materials: Steady demand for both decoration and metallized paper Devices: Despite sluggish demand, profitability improved by the factory consolidation, etc. Medical Technologies:
Slide 3: FY2025 Q1 (3 months) Results
FY2025 Q1 (3 months) Results (Millions of JPY) 2024 Q1 2024 Q4 2025 Q1 Results Results Results YoY QoQ Net sales 46,719 47,196 47,442 +1.5% +0.5% Industrial Materials 17,841 18,776 18,785 +5.3% +0.0% Devices 16,569 14,161 13,558 -18.2% -4.3% Medical Technologies 10,069 11,984 11,948 +18.7% -0.3% Oth
Slide 4: Industrial Materials: Q1 Results, Q2 Forecast (QoQ)
Industrial Materials: Q1 Results, Q2 Forecast (QoQ) Quarterly net sales and operating profit margin ■Sustainable Materials ■Decoration (Mobility) (Metallized paper and others) ●Operating profit margin Q1 Results (Forex: ¥153/$) ■Decoration (Home appliances Decoration: Both mobility and home and o
Slide 5: A new factory for mobility exteriors in Germany completed on April 28
A new factory for mobility exteriors in Germany completed on April 28 In addition to interior decoration, exterior decoration will grow Mass production from Q4, 2025 New Logistics Front section (grille, lights, etc.) Interior Decoration Sustainable Molding Thuringia, Germany Rear section (lights,
Slide 6: Devices: Q1 Results, Q2 Forecast (QoQ)
Devices: Q1 Results, Q2 Forecast (QoQ) Quarterly net sales and operating profit margin ■Handheld terminals (logistics related), Mobility, Q1 Results (Forex: ¥153/$) Gaming devices, Gas sensors and others Tablet devices: Weak demand ■Tablet devices ■Smartphones ●Operating profit margin (higher th
Slide 7: Medical Technologies: Q1 Results, Q2 Forecast (QoQ)
Medical Technologies: Q1 Results, Q2 Forecast (QoQ) Quarterly net sales and operating profit margin ■Business media ●Operating profit margin ■Medical devices (Own brand) ■Medical devices (CDMO) Q1 Results (Forex: ¥153/$) (Millions of JPY) Medical devices (CDMO): Steady demand 11,954 11,613 11,98
Slide 8: Impact of Trump Tariffs
Impact of Trump Tariffs Direct impact is limited, as most of the net sales to the USA are generated through local production Industrial About 80% of the net sales to the USA through local Devices Materials production 2.0 (Decoration) ■Industrial Materials (Decoration): 2 molding factories in the
Slide 9: FY2025 Plan
FY2025 Plan No change in plan, limited direct impact of tariffs (not reflected) (Millions of JPY) 2024 2025 Full-year Full-year H1 H2 YoY Result Plan Plan Plan Net sales 195,598 190,800 92,400 98,400 -2.5% Industrial Materials 74,090 75,700 37,400 38,300 +2.2% Devices 67,542 55,200 25,600 29,600 -
Slide 10: Investor Conference
Investor Conference Growth in the Medical Market (Medical devices CDMO /Pharmaceuticals CDMO) Date and time: June 24, Tuesday, 11:00 am-12:30 pm Meeting format: On-site and live streaming Venue: Belle Salle Tokyo Nihonbashi Attendee Junya Suzuki , Chairman of the Board and Group CEO
Slide 11: (Reference) Capital investment, Depreciation and amortization, M&A investment, R&D (FY2025)
(Reference) Capital investment, Depreciation and amortization, M&A investment, R&D (FY2025) (Millions of JPY) Q1 Results Capital investment 3,033 Depreciation and 2,429 amortization M&A investment 9,500 R&D 1,034 ©2025 Nissha Group 11
Slide 12: Among the information included in this presentation and provided at investor briefings and conferences,
Among the information included in this presentation and provided at investor briefings and conferences, performance targets, plans, outlooks, strategies and other information that is not constituted of actual past facts, is information that has been judged reasonable by the managers of the Company b